Trosman JR - Search Results

1

Capacity building for assessing new technologies: approaches to examining personalized medicine in practice.

Van Bebber SL, Trosman JR, Liang SY, Wang G, Marshall DA, Knight S, Phillips KA. Van Bebber SL, et al. Among authors: trosman jr. Per Med. 2010 Jul;7(4):427-439. doi: 10.2217/pme.10.36. Per Med. 2010. PMID: 21857867 Free PMC article.

2

Coverage policy development for personalized medicine: private payer perspectives on developing policy for the 21-gene assay.

Trosman JR, Van Bebber SL, Phillips KA. Trosman JR, et al. J Oncol Pract. 2010 Sep;6(5):238-42. doi: 10.1200/JOP.000075. J Oncol Pract. 2010. PMID: 21197187 Free PMC article.

3

Health technology assessment and private payers' coverage of personalized medicine.

Trosman JR, Van Bebber SL, Phillips KA. Trosman JR, et al. J Oncol Pract. 2011 May;7(3 Suppl):18s-24s. doi: 10.1200/JOP.2011.000300. J Oncol Pract. 2011. PMID: 21886515 Free PMC article.

4

The economic value of personalized medicine tests: what we know and what we need to know.

Phillips KA, Ann Sakowski J, Trosman J, Douglas MP, Liang SY, Neumann P. Phillips KA, et al. Genet Med. 2014 Mar;16(3):251-7. doi: 10.1038/gim.2013.122. Epub 2013 Oct 17. Genet Med. 2014. PMID: 24232413 Free PMC article.

5

Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.

Trosman JR, Weldon CB, Douglas MP, Deverka PA, Watkins JB, Phillips KA. Trosman JR, et al. Value Health. 2017 Jan;20(1):40-46. doi: 10.1016/j.jval.2016.09.2402. Value Health. 2017. PMID: 28212967 Free PMC article.

6

"What Goes Around Comes Around": Lessons Learned from Economic Evaluations of Personalized Medicine Applied to Digital Medicine.

Phillips KA, Douglas MP, Trosman JR, Marshall DA. Phillips KA, et al. Among authors: trosman jr. Value Health. 2017 Jan;20(1):47-53. doi: 10.1016/j.jval.2016.08.736. Value Health. 2017. PMID: 28212968 Free PMC article.

7

Health technology assessment and private payers's coverage of personalized medicine.

Trosman JR, Van Bebber SL, Phillips KA. Trosman JR, et al. Am J Manag Care. 2011 May;17 Suppl 5 Developing:SP53-60. Am J Manag Care. 2011. PMID: 21711078 Free article.

8

Genomic sequencing: assessing the health care system, policy, and big-data implications.

Phillips KA, Trosman JR, Kelley RK, Pletcher MJ, Douglas MP, Weldon CB. Phillips KA, et al. Among authors: trosman jr. Health Aff (Millwood). 2014 Jul;33(7):1246-53. doi: 10.1377/hlthaff.2014.0020. Health Aff (Millwood). 2014. PMID: 25006153 Free PMC article.

9

Payer decision making for next-generation sequencing-based genetic tests: insights from cell-free DNA prenatal screening.

Dervan AP, Deverka PA, Trosman JR, Weldon CB, Douglas MP, Phillips KA. Dervan AP, et al. Among authors: trosman jr. Genet Med. 2017 May;19(5):559-567. doi: 10.1038/gim.2016.145. Epub 2016 Sep 22. Genet Med. 2017. PMID: 27657682 Free PMC article.

10

Private payer coverage policies for exome sequencing (ES) in pediatric patients: trends over time and analysis of evidence cited.

Douglas MP, Parker SL, Trosman JR, Slavotinek AM, Phillips KA. Douglas MP, et al. Among authors: trosman jr. Genet Med. 2019 Jan;21(1):152-160. doi: 10.1038/s41436-018-0043-3. Epub 2018 Jul 12. Genet Med. 2019. PMID: 29997388 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters